Canada PharmAla Biotech initiates MDMA supplier agreement with InterVivo Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses Rowan DunneAugust 5, 2022
Psychedelics WITHIN ‘Ceremonial Psychedelic Treatment Center’ opens in Texas New clients offer detailed enthusiastic feedback thus far Rowan DunneAugust 2, 2022
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Psychedelics Field Trip administers new synthetic molecule in Australia Initial dose of FT-104 given in Adelaide, company announces name change Rowan DunneJuly 22, 2022
Psychedelics Delic Holdings highlights financial success and continues expanding KWC Canadian company continues to develop its presence in the clinical psychedelic sector Rowan DunneJuly 21, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022
Psychedelics MAPS now providing digital psychedelic education Psychedelic Fundamentals course to provide broad overview of a vast topic Rowan DunneJuly 14, 2022
Psychedelics Filament Health undertakes innovative clinical trial FDA-approved psilocin study in California said to be first of its kind for industry Rowan DunneJuly 11, 2022